Madagascar Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Madagascar Health Press.

Press releases published on October 7, 2026

35 minutes ago

Perspective Therapeutics Announces Acceptance of [212Pb]VMT-α-NET Data for Presentation at the NANETS 2026 Multidisciplinary NET Medical Symposium

Indeterminate GlobeNewswire

an hour ago

Teladoc Health Expands Solo Connected Care Platform with AI-Powered Capabilities to Help Hospitals Scale Smarter Care Delivery

Indeterminate GlobeNewswire

an hour ago

New study finds a majority of younger men spend an unhealthy amount of time on social media, significantly impacting their mental health

Indeterminate GlobeNewswire

an hour ago

Une nouvelle étude révèle qu’une majorité de jeunes hommes passent un temps excessif sur les médias sociaux, ce qui peut avoir des répercussions importantes sur leur santé mentale

Indeterminate GlobeNewswire

2 hours ago

MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class Muscle Regeneration Therapy in Stress Urinary Incontinence

Indeterminate GlobeNewswire

2 hours ago

ITM and Lumara Bio to Announce New Data for ¹⁷⁷Lu-edotreotide (ITM-11) and Ga-DPI-4452 at EANM 2026

Indeterminate GlobeNewswire

2 hours ago

Dubai Sets the Stage for the Future of Healthcare with Next Generation Medicine 2026

Indeterminate GlobeNewswire

3 hours ago

BIO-Europe C-Suite Survey: Biopharma dealmaking set to accelerate, but investor caution still caps ambition

Indeterminate GlobeNewswire

4 hours ago

PulseSight presents PST-611 Phase I new early clinical efficacy data at EURETINA, offering a potential breakthrough approach to treat Dry AMD/Geographic Atrophy

Indeterminate GlobeNewswire

5 hours ago

Oculis to Highlight Licaminlimab at Eyecelerator @ AAO 2026 and Partner with Neuro-Ophthalmology Subspecialty Day

Indeterminate GlobeNewswire

6 hours ago

Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia

Indeterminate GlobeNewswire

8 hours ago

Vaxcyte Announces Pricing of Concurrent Public Offerings of Common Stock, Pre-Funded Warrants and Convertible Senior Notes

Indeterminate GlobeNewswire

10 hours ago

OGRD Alliance Advances PLPC Multi-Asset Platform Following APHELAR Milestone, Expanding Licensing and Strategic Capital Frameworks

Indeterminate GlobeNewswire